Hidradenitis suppurativa (HS) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051119

HS restriction and item codes

Do not release this attachment externally. See Freedom of Information - Information Publication Scheme.

$\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.png$ PBS HS restriction and item codes

Contact details

PBS Complex Drugs Programs

Forms

Moderate to severe hidradenitis suppurativa - initial, change or recommencement authority application (PB218)

Moderate to severe hidradenitis suppurativa - secukinumab - initial grandfather authority application (PB364)

Moderate to severe hidradenitis suppurativa - continuing authority application (PB219)

Services Australia website

Hidradenitis Suppurativa

External websites

PBS schedule for Hidradenitis suppurativa

FAQs from Service Officers

Table 1: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs.

Item	Description
1	How many failures are allowed in one treatment cycle for PBS-subsidised treatment of hidradenitis suppurativa (HS)? Three. There are only two biological medicines PBS listed to treat HS. Patients can fail one biological medicine twice within the same treatment cycle.
2	How many prescriptions or details of the proposed prescriptions are required for the initial/change/recommencement of treatment with adalimumab? Two. They are for: loading - written for a quantity of 6 (of 40 mg) or 3 (of 80 mg) and no repeats, with 160 mg administered at week 0, 80 mg at week 2 and 40 mg weekly starting at week 4 balance of 16 weeks of treatment - with a quantity of 4 (of 40 mg) or 2 (of 80 mg) and 2 repeats
3	How many prescriptions or details of the proposed prescriptions are required for the initial/change/recommencement of treatment with secukinumab? When there is: an induction regimen intended - 2 prescriptions, or details of the proposed prescriptions are needed. A prescription for the: induction - for a quantity of 8 doses of 150 mg and no repeats maintenance - 2 (or 4) doses of 150 mg and 3 repeats no loading dose requested - 1 prescription or details of the proposed prescription for a quantity of 2 (or 4) doses of 150 mg and 3 repeats. Note: see HS code sheet for the correct item code(s), quantity and repeats to be entered in the OPA system.
4	Can increased quantity and/or repeats be authorised for secukinumab? The quantity of secukinumab can be increased from 2 to 4 for all treatment phases (excluding the induction) if the patient is dosed at 300 mg per fortnight. No increase in the maximum number of listed repeats can be authorised. Note: see HS code sheet for details.